Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES)
Laufzeit: 01.01.2006 - 31.12.2009
Laufzeit: 01.01.2006 - 31.12.2009
To compare the functional and anatomic outcomes of chronic macular edema secondary to branch retinal vein occlusion (BRVO) treated with argon laser photocoagulation versus intravitreal ranibizumab (Lucentis) injection versus a combination of both